Skip to main content
. Author manuscript; available in PMC: 2021 May 28.
Published in final edited form as: Adv Drug Deliv Rev. 2020 May 28;154-155:245–273. doi: 10.1016/j.addr.2020.05.006

Table 3.

Mechanism of the CHMs that promote blood circulation and remove blood stasis and their active components on tumor cells and the TME.

CHMs Active components Tumor cells TME Blood circulation References
Apoptosis induction Proliferation inhibition Autophagy regulation Anti-multidrug resistance Migration and invasion inhibition Anti-angiogenesis Tregs Platelet aggregation
Panax notoginseng (san qi) Notoginsenoside R1, R7, and Ft1 [218221]
Rhizome chuanxiong (chuan xiong) Ligustrazine [222,223]
Salvia miltiorrhiza (dan shen) Tanshinone I and IIA [224226]
Cryptotanshinone [226,227]
Rosmarinic acid [228230]
Danshensu [231]
Salvianolic acid [232,233]
Dihydrotanshinone [234236]
Crocus sativus (xi hong hua) Crocin and Crocetin [237239]
Erigeron breviscapus (deng zhan xi xin) Scutellarin [240,241]
Flos carthami (hong hua) Hydroxysafflor yellow A [242,243]
Rhodiola rosea (hong jing tian) Salidroside [244,245]
Cortex moutan radicis (mu dan pi) Paeonol [246,247]
Ardisia japonica (ai di cha) Bergenin [248]
Peach kernel (tao ren) Amygdalin [249,250]
Naringenin [9,251,252]
Rhizoma curcumae (e zhu) Curcumin [9,253256]
Curcumol [257,258]